These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Microparticles in vascular disorders: how tissue factor-exposing vesicles contribute to pathology and physiology. Kleinjan A; Böing AN; Sturk A; Nieuwland R Thromb Res; 2012 Oct; 130 Suppl 1():S71-3. PubMed ID: 23026670 [TBL] [Abstract][Full Text] [Related]
5. The role of procoagulants and anticoagulants in the development of venous thromboembolism. Bertina RM Thromb Res; 2009; 123 Suppl 4():S41-5. PubMed ID: 19303503 [TBL] [Abstract][Full Text] [Related]
6. Role of selectins and fibrinolysis in VTE. Wakefield TW; Myers DD; Henke PK Thromb Res; 2009; 123 Suppl 4():S35-40. PubMed ID: 19303502 [TBL] [Abstract][Full Text] [Related]
7. Cardiovascular risk factors in idiopathic compared to risk-associated venous thromboembolism: A focus on fibrinogen, factor VIII, and high-sensitivity C-reactive protein (hs-CRP). Luxembourg B; Schmitt J; Humpich M; Glowatzki M; Dressler D; Seifried E; Lindhoff-Last E Thromb Haemost; 2009 Oct; 102(4):668-75. PubMed ID: 19806251 [TBL] [Abstract][Full Text] [Related]
8. Platelet microparticles and vascular cells interactions: a checkpoint between the haemostatic and thrombotic responses. Morel O; Morel N; Freyssinet JM; Toti F Platelets; 2008 Feb; 19(1):9-23. PubMed ID: 18231934 [TBL] [Abstract][Full Text] [Related]
10. Venous thromboembolism and arterial complications. Prandoni P; Piovella C; Pesavento R Semin Respir Crit Care Med; 2012 Apr; 33(2):205-10. PubMed ID: 22648494 [TBL] [Abstract][Full Text] [Related]
11. The role of inflammation in venous thromboembolism and the link between arterial and venous thrombosis. Poredos P; Jezovnik MK Int Angiol; 2007 Dec; 26(4):306-11. PubMed ID: 18091697 [TBL] [Abstract][Full Text] [Related]
12. Pathogenesis of venous thromboembolism: when the cup runneth over. Lippi G; Franchini M Semin Thromb Hemost; 2008 Nov; 34(8):747-61. PubMed ID: 19214913 [TBL] [Abstract][Full Text] [Related]
14. Increased levels of microparticles originating from endothelial cells, platelets and erythrocytes in subjects with metabolic syndrome: relationship with oxidative stress. Helal O; Defoort C; Robert S; Marin C; Lesavre N; Lopez-Miranda J; Risérus U; Basu S; Lovegrove J; McMonagle J; Roche HM; Dignat-George F; Lairon D Nutr Metab Cardiovasc Dis; 2011 Sep; 21(9):665-71. PubMed ID: 20399083 [TBL] [Abstract][Full Text] [Related]
15. Cell-derived microparticles: a new challenge in neuroscience. Doeuvre L; Plawinski L; Toti F; Anglés-Cano E J Neurochem; 2009 Jul; 110(2):457-68. PubMed ID: 19457085 [TBL] [Abstract][Full Text] [Related]
16. Risk assessment as a guide for the prevention of the many faces of venous thromboembolism. Caprini JA Am J Surg; 2010 Jan; 199(1 Suppl):S3-10. PubMed ID: 20103082 [TBL] [Abstract][Full Text] [Related]